|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-3-14
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Malaria in Zambia remains a public health and developmental challenge, affecting mostly children under five and pregnant women. In 2002, the first-line treatment for uncomplicated malaria was changed to artemether-lumefantrine (AL) that has proved to be highly efficacious against multidrug resistant Plasmodium falciparum.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-10681341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-11044263,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-14998421,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-15850630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16163624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16163625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16195289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16766006,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16798391,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-16923176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-17336652,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-17525792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-18230140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-19936217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-350347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-7611566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21352609-9705187
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1475-2875
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
50
|
|
pubmed:dateRevised |
2011-7-27
|
|
pubmed:meshHeading |
pubmed-meshheading:21352609-Antimalarials,
pubmed-meshheading:21352609-Artemisinins,
pubmed-meshheading:21352609-Child, Preschool,
pubmed-meshheading:21352609-Drug Combinations,
pubmed-meshheading:21352609-Ethanolamines,
pubmed-meshheading:21352609-Fluorenes,
pubmed-meshheading:21352609-Humans,
pubmed-meshheading:21352609-Infant,
pubmed-meshheading:21352609-Malaria, Falciparum,
pubmed-meshheading:21352609-Plasmodium falciparum,
pubmed-meshheading:21352609-Quinolines,
pubmed-meshheading:21352609-Treatment Outcome,
pubmed-meshheading:21352609-Zambia
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
|
|
pubmed:affiliation |
Department of Clinical Sciences, Tropical Disease Research Center, P,O Box 71769, Ndola Zambia. michaelnambozi@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
